Where does Gencurix Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Gencurix Inc. ranks #26,365 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Gencurix Inc. hold?

Gencurix Inc. holds 10 US utility patents granted between 2017 and 2024, spanning 3 technology areas.

What is Gencurix Inc.'s Innovation Score?

Gencurix Inc. has an Innovation Score of 22.9 out of 100 (11th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Gencurix Inc.'s patent grant rate increasing or decreasing?

Gencurix Inc.'s recent grant velocity is +133% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Gencurix Inc.'s patents?

Gencurix Inc.'s patents average 5.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Gencurix Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Gencurix Inc.

Q: What technology areas does Gencurix Inc. focus on?

Gencurix Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 10 patents, ranking #452 of 2,502 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 10 granted patents across 3 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Gencurix ranks #26,365 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 3 technology areas.

#26,365
of 49,997 US assignees by volume: 11th percentile
by Innovation Score (22.9/100): 5.3
avg claims per patent: +133%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R26365 · Foreign Corporation #26,365 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #26,365/49,997
PHOTO-FINISH Gauzy
CPC-NARROW C12Q · 3 areas
INNOV-THIN 22.9/100
CLAIMS-SPARSE 5.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +133% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Gauzy Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Gencurix’s 22.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.3 pts (36%) Velocity 5.3 pts (23%) Breadth 6.1 pts (27%) Claim depth 3.2 pts (14%)

Qualcomm Incorporated · highest

85
Phoenix Industries Pty · near

23
Super73 · near

23
Siargo · near

23
Gencurix · this assignee

23
Proteometech · near

23
3D Lighting… · lowest

7

What this shows Gencurix's Innovation Score is 22.9/100 (11th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Gencurix?

Each dot is one of Gencurix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Gencurix’s own 5.3 claims/patent is at or below the 13.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Gencurix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Gencurix's grants concentrate

Gencurix Inc. is a focused PatentsView assignee: 3 CPC subclasses with 100% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2019 (2 grants) versus a trough of 1 in 2017. By volume, Gencurix sits between G.I. View Ltd. and Giken Ltd..

Gencurix's three-year grant acceleration

Gencurix Inc. shows 4 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

G I View

10
Gauzy

10
Gbrs Group

10
GE Inspection

10
General Automatio…

10
Genesis Technolog…

10
Genus Oncology

10
Giken

10
Gencurix ◀

10

What this shows Gencurix holds 10 patents at rank #26,355, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Gencurix

By rank, the assignees closest to #26,355 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Gencurix's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Gencurix, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Gencurix ranks #452 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (23 here).

Proteometech Inc. 23 Siargo Ltd. 23 Super73, Inc. 23 Phoenix Industries Pty Ltd 23

Gencurix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

23 11th percentile higher than 11% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Gencurix Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	10.0%
2019	2	20.0%
2020	2	20.0%
2021	1	10.0%
2022	2	20.0%
2023	1	10.0%
2024	1	10.0%

Which technologies does Gencurix Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 10

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Gencurix Inc.'s patent record in context - here's where to go next.

Gencurix Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 100% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #26,365 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Gencurix Inc. against G.I. View Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 22.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.